3mg Liraglutide for Overweight or Obesity

CompletedOBSERVATIONAL
Enrollment

43

Participants

Timeline

Start Date

January 18, 2019

Primary Completion Date

December 18, 2020

Study Completion Date

December 18, 2020

Conditions
OverweightObesityInfertility, Female
Interventions
DRUG

Saxenda

Obesity pharmacotherapy

OTHER

Lifestyle modification

Tier 3 NHS weight management

DIAGNOSTIC_TEST

Metabolomics

Small molecule intermediates and products of metabolism

DIAGNOSTIC_TEST

miRNA

Small non-coding RNA molecules

Trial Locations (1)

CV2 2DX

WISDEM Centre, University Hospitals Coventry and Warwickshire, Coventry

All Listed Sponsors
collaborator

Kingston University

OTHER

collaborator

University of Warwick

OTHER

collaborator

University of Birmingham

OTHER

lead

University Hospitals Coventry and Warwickshire NHS Trust

OTHER

NCT03885297 - 3mg Liraglutide for Overweight or Obesity | Biotech Hunter | Biotech Hunter